ABSTRACT
Objective/Research Question: To assess the effect of chemotherapy on invasive disease–free survival (IDFS) in women with 1–3 node-positive, hormone receptor–positive, HER2-negative, invasive breast cancer. It also looked to establish if a relationship exists between a higher recurrence score (RS) and increased benefit from chemotherapy.
